HowardMSandlerMDFASTRO

PubMed

• A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer.
  C Noel Bairey Merz, Aum J Solanki, Mitchell Kamrava, Edwin M Posadas, Stephen J Freedland, Leslie Ballas, Howard M Sandler, Katelyn M Atkins, Andriana P Nikolova> ;Cancer. 2024 Mar 26
• Variation in communication of side effects in prostate cancer treatment consultations.
  Gale, R., Luu, M., Friedrich, N., Venkataramana, A., Khodyakov, D., Spiegel, B., Daskivich, T., Naser-Tavakolian, A., Posadas, E., Sandler, H., Freedland, S.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 23
• Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations.
  Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, John M Masterson, Abhishek Venkataramana, Dmitry Khodyakov, Jennifer T Anger, Edwin Posadas, Howard Sandler, Stephe...> ;Medical Decision Making. 2024 Apr 1
• Feasibility and acceptability of ChatGPT generated radiology report summaries for cancer patients.
  Zhang, S., Nguyen, A., Atkins, K., Sandler, H., Kamrava, M., Chung, E.> ;Digital Health. 2023 Dec 19
• 1 citations
  Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.
  Brandon A Mahal, Lucia Kwak, Wanling Xie, James A Eastham, Nicholas D James, Howard M Sandler, Felix Y Feng, Meryem Brihoum, Karim Fizazi, Christopher Sweeney, Praful ...> ;JAMA Network Open. 2023 Nov 1
• Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?
  Jun Gong, Daniel M Kim, Amanda M De Hoedt, Neil Bhowmick, Robert Figlin, Hyung L Kim, Howard Sandler, Dan Theodorescu, Edwin Posadas, Stephen J Freedland> ;Journal of Clinical Oncology. 2024 Jan 10
• Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
  Spratt, D., Tang, S., Sun, Y., Huang, H., Chen, E., Mohamad, O., Armstrong, A., Tward, J., Nguyen, P., Lang, J., Zhang, J., Mitani, A., Simko, J., DeVries, S., van der...> ;NEJM Evidence. 2023 Aug 1
• 3 citations
  Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
  Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, Elai Davicioni, Alejandro Berlin, Jeffry P Simko, Jason A Efstathiou, Phuoc T Tran, Howard M Sandler, William A Hall, ...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Oct 1
• 5 citations
  The American Society for Radiation Oncology Workforce Taskforce Review of the United States Radiation Oncology Workforce Analysis.
  Chirag Shah, Pranshu Mohindra, Anna Arnone, James Edward Bates, Malcolm D Mattes, Shauna Campbell, Hiral P Fontanilla, Austin J Sim, Hadley J Sharp, Patrick Kelly, Con...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 1
• Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
  Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko, Sandy DeVries, Emmalyn Chen, Edward M Schaeffer, Todd M Morgan, Yilun Sun, Amirata Ghorba...> ;NPJ Digital Medicine. 2023 Feb 22
• 4 citations
  Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs.
  Jasmine J Wang, Na Sun, Yi-Te Lee, Minhyung Kim, Tatyana Vagner, Krizia Rohena-Rivera, Zhili Wang, Zijing Chen, Ryan Y Zhang, Junseok Lee, Ceng Zhang, Hubert Tang, Jos...> ;Nano Today. 2023 Feb 1
• Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415.
  Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, Katherine A Yeager, Qi Zhang, W Robert Lee, Amit B Shah, Ian S Dayes, David P D'Souza, Jeff M Michalski, Jason A Efstat...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 May 1
• 1 citations
  Recent Trends in Medicare Payments for Outpatient Cancer Care at the End of Life.
  Constantine A Mantz, Catheryn M Yashar, Gopal K Bajaj, Howard M Sandler> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 15
• 1 citations
  Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
  John M Masterson, Michael Luu, Aurash Naser-Tavakolian, Stephen J Freedland, Howard Sandler, Zachary S Zumsteg, Timothy J Daskivich> ;Prostate Cancer and Prostatic Diseases. 2023 Jan 4
• 7 citations
  Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Pha...
  Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, Elai Davicioni, Howard M Sandler, William U Shipley, Jason A Efstathiou, Jeffry P Simko, Alan Pollack, Adam P...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 1
• 13 citations
  Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
  Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, Jean-Paul Bahary, Colleen A F Lawton, Jason A Efstathiou, Rajat J Kudchadker, Lee E Ponsky, Samantha A Seaward, Ia...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 15
• 3 citations
  Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
  Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, John M Hoyle, Andrew Lenzie, Grant R Williams, Jeff M Michalski, Don Yee, Jean-Paul Bahary, Robert B Den, Mack Roach 3...> ;Cancer. 2023 Mar 1
• 1 citations
  Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for ...
  Abhishek A Solanki, Lindsay L Puckett, Ksenija Kujundzic, Evangelia Katsoulakis, John Park, Rishabh Kapoor, Michael Hagan, Maria Kelly, Jatinder Palta, Leslie K Ballas...> ;Practical Radiation Oncology. 2022 Dec 9
• 11 citations
  Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
  Ting Martin Ma, Yilun Sun, Shawn Malone, Mack Roach 3rd, David Dearnaley, Thomas M Pisansky, Felix Y Feng, Howard M Sandler, Jason A Efstathiou, Isabel Syndikus, Emma ...> ;Journal of Clinical Oncology. 2023 Feb 1
• 1 citations
  The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply.
  Alan Pollack, Theodore G Karrison, Felix Feng, Oliver Sartor, Howard M Sandler> ;Lancet. 2022 Sep 17
• 2 citations
  Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment.
  Zachary A Seymour, Stephanie Daignault-Newton, Howard Sandler, William Jackson, Skyler B Johnson, David Miller, John Wei, Martin Sanda, Daniel A Hamstra, McLaughlin, P.> ;Clinical and Translational Radiation Oncology. 2022 Sep 1
• ASTRO Supports Access to Evidence-Based Cancer Care for All Patients, Regardless of Pregnancy Status, and Protection for Physicians Recommending and Providing Evidence...
  Geraldine M Jacobson, Gopal K Bajaj, John M Buatti, Laura Dawson, Curtiland Deville, Thomas J Eichler, Beth Erickson, Eric Ford, Iris C Gibbs, Constantine Mantz, Brian...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 1
• 26 citations
  Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of t...
  Ting Martin Ma, Fang-I Chu, Howard Sandler, Felix Y Feng, Jason A Efstathiou, Christopher U Jones, Mack Roach 3rd, Seth A Rosenthal, Thomas Pisansky, Jeff M Michalski,...> ;European Urology. 2022 Nov 1
• 14 citations
  High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analy...
  Amar U Kishan, Xiaoyan Wang, Yilun Sun, Tahmineh Romero, Jeff M Michalski, Ting Martin Ma, Felix Y Feng, Howard M Sandler, Michel Bolla, Philippe Maingon, Theo De Reij...> ;European Urology. 2022 Jul 1
• 10 citations
  Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.
  William C Jackson, Ming Tang, Matthew J Schipper, Howard M Sandler, Zachary S Zumsteg, Jason A Efstathiou, William U Shipley, Wendy Seiferheld, Himanshu R Lukka, Jean-...> ;Journal of Clinical Oncology. 2022 Sep 20
• Join now to see all

Journal Articles

• Adjuvant post-operative radiotherapy following radical prostatectomy: Is now the time?  
  Sandler HM, Nature Clinical Practice Oncology 3:84-85
• Exploring dose-intensity: carefully comparing high-dose with low-dose external-beam radiotherapy for prostate cancer.  
  Sandler HM, J Clin Oncol 24:1975-1977
• Advanced prostate cancer and postoperative radiotherapy.  
  Pisansky TM, Pollack A, Sandler HM, Valicenti RK, JAMA 297:950-951
• Issue guest.  
  Sandler HM, Lawrence TS, Accompanying editorial Cancer Journal 13:287-288
• Prostate cancer matters.  
  Sandler HM, Semin Radiat Oncol. 18:1
• The effect of patient position and treatment technique in conformal treatment of prostate cancer.  
  McLaughlin PW, Wygoda A, Sahijdak W, Sandler HM, Marsh L, Roberson P, Ten Haken RK, Int J Radiat Oncol Biol Phys 45:407-413
• A phase 3 randomized study of radiotherapy plus procarbazine, CCNU and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: A preliminar...  
  Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran W, Int J Radiat Oncol Biol Phys 45:1109-1115
• Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.  
  Michalski JM, Purdy JA, Winter K, Roach M, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD, Int J Radiat Oncol Biol Phys 46:391-402
• 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review.  
  Fiveash JB, Hanks G, Roach M, Wang S, Vigneault E, McLaughlin PW, Sandler HM, Int J Radiat Oncol Biol Phys 47:335-342
• Prostate position late in the course of external beam therapy: Patterns and predictors.  
  Zellars RC, Roberson PL, Strawderman M, Zhang D, Sandler HM, Ten Haken RK, Osher D, McLaughlin PW, Int J Radiat Oncol Biol Phys 47:655-660
• Stereotactic radiosurgery of cerebral arteriovenous malformations using a multileaf collimator and a single isocenter.  
  Ross DA, Sandler HM, Balter JM, Hayman JA, Deveikis J, Auer DL, Neurosurgery 47:123-128
• A comparison of ventilatory prostate movement in four treatment positions.  
  Dawson LA, Litzenberg DW, Brock KK, Sanda M, Sullivan M, Sandler HM, Balter JM, Int J Radiat Oncol Biol Phys 48:319-323
• Overall survival remains high after PSA failure following conformal external beam radiotherapy.  
  Sandler HM, Dunn RL, McLaughlin PW, Hayman JA, Sullivan MA, Taylor JMG, Int J Radiat Oncol Biol Phys 48:629-633
• Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate c...  
  Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG, Urology 56:899-905
• Definitions of biochemical failure in prostate cancer following radiation therapy.  
  Taylor JMG, Griffith KA, Sandler HM, Int J Radiat Oncol Biol Phys 50:1212-1219
• Genitourinary Cancer Committee.  
  Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, DeSilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, Lee WR, M..., Int J Radiat Oncol Biol Phys 51(3 Suppl 2):28-38
• Radiation Therapy Oncology Group. Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee.  
  Michalski J. Purdy JA. Gaspar L. Souhami L. Ballow M. Bradley J. Chao CK. Crane C. Eisbruch A. Fallowil D. Forster K. Fowler J. Gillin MT. Graham ML. Harms WB. Huq MS...., Int J Radiat Oncol Biol Phys. 51(3 Suppl 2):60-5
• Radiation Therapy Oncology Group. Radiation Therapy Oncology Group. Research Plan 2002-2006. Tumor Utilization Committee.  
  Hammond ME. Ang K. Byhardt R. Campbell B. Chapman JD. Eisenberg B. Greven K. Harris J. Hoffman J. Lange C. McCormick B. Mehta M. Sandler H. Trotti A. Willet C. Wolfson..., Int J of Radiat Oncol, Biol Phys. 51(3 Suppl 2):103-9
• Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.  
  Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JM, Litwin MS, Nyquist L, Sanda MG, J Clin Oncol 20:557-566
• Daily prostate targeting using implanted radio-opaque markers.  
  Litzenberg DW, Dawson LA, Sandler H, Sanda MG, McShan DL, Ten Haken RK, Lam KL, Brock KK and Balter JM, Int J Radiat Oncol Biol Phys 52:699-703
• Survival and failure patterns of high-grade gliomas following 3-D conformal radiotherapy.  
  Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, Sandler HM, J Clin Oncol 20:1635-1642
• Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.  
  Ross DA, Sandler HM, Balter JM, Hayman JA, Archer PG, Auer DL, Journal of Neuro-Oncology 56:175-81
• Survey of radiation oncologists: practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United States.  
  Choo R. Sandler H. Warde P. Hruby G. DeBoer G, Canadian Journal of Urology. 9:1479-85
• The influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy.  
  Pan CC, Kim KY, Taylor JMG, McLaughlin PW, Sandler HM, Int J Radiat Oncol Biol Phys 53:1139-1145
• Utilities as a measure of the benefit of radiation therapy following orchiectomy for stage I seminoma.  
  Chan JL, Kabeto MU, Bennett JE, Oldread AE, Paisley KL, Sandler HM, Smith DC, Hayman JA, Int J Radiat Oncol Biol Phys 53:934-941
• Join now to see all

Books/Book Chapters

•  
  Greenberg HS, Chandler WF, Sandler HMPhiladelphia: FA Davis Co
•  
  Howard M. SandlerEditors: Nargund V, Raghavan D, Sandler HM.Springer
•  
  Howard M. SandlerEditors: Gulley JL, Dahut WL, Moul JW, Sandler HM.Lippincott, Williams & Wilkins
•  
  Page 176 - 181Greenberg HS, Chandler WF, Ensminger WD, Junck L, Page MA, Thornton AF, Sandler HM, Gebarski SS, McKeever P, Papadopoulos S, Stetson PL, Tankanow REditors: European Review of Biomedical Technology Paris, France.Sepsi Publishing
•  
  Page 217 - 219Greenberg HS, Chandler WF, Ensminger WD, Junck L, Thornton A, Sandler HM, Page MA, McKeever P, Gebarski S, Liang B, Tankanow REditors: Paoletti P.Kluwer Academic Publishers
•  
  Lichter AS, Sandler HM, Thornton AF, Schoeppel SL, Lawrence TSEditors: Dewey WC, Edington M, Fry RJM, Hall J, Whitmore GF.
•  
  Chapter: Radiation Oncology: A Question-Based Review 
  Zeng J and Sandler HEditors: Hristov B, Lin SH, Christodouleas JP.Lippincott
•  
  Chapter: Abeloff’s Clinical Oncology 
  Smith DC, Montie JE, Sandler HMEditors: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG.Churchill Livingstone, New YorkEdition 4,
•  
  Chapter: Prostate Cancer: A Clinical Guide. Philadelphia 
  Sandler HMEditors: Gulley JL, Dahut WL, Moul JW, Sandler HM.Lippincott, Williams & Wilkins
•  
  Chapter: Clinical Oncology 
  Montie JE, Smith DC, Sandler HMEditors: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG.Churchill Livingstone, New York
•  
  Pienta, KJ, Sandler H, Javidan J, Sanda MGEditors: Pazdur R, Coia LR, Hoskins WJ, Wagman LD.Huntington, NY
•  
  Chapter: Carcinoma of the bladder 
  Montie JE, Smith DC, Sandler HMEditors: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE.Churchill Livingstone, New YorkEdition 2,
•  
  Chapter: The biological effects of ionizing radiation on normal and abnormal nervous systems 
  Lee SW, Sandler HMEditors: : Crockard A, Hayward R, and Hoff J.Blackwell ScienceEdition 3,
•  
  Chapter: Melanoma 
  Chang AE, Johnson TM, Smith DC, Sandler HMEditors: Torosian MH.Marcel Dekker, New York
•  
  Chapter: Non-axial, external beam treatment for prostate cancer 
  Sandler HMEditors: D'Amico A and Hanks GE.Arnold, Ltd, London
•  
  Pienta KJ, Sandler HM, Wilson TGEditors: Pazdur R, Coia LR, Hoskins WJ, Wagman LD.Huntington, NYEdition 2,
•  
  Chapter: Grade 2 toxicity on RTOG 9406: Robbing Peter to pay Paul? 
  Page 48 - 54Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament MB, Pollack A, Markoe A, Harms WB, Sandler HM, Cox JDEditors: Paliwal BR.Medical Physics Publishing
• Join now to see all

Abstracts/Posters

• Clinical experience with 3-dimensional treatment planning.
  Lichter AS, Sandler HM, Robertson JM, Lawrence TS, Ten Haken RK, McShan DL, Fraass BA, Seminars in Radiation Oncology 2:257-266
• Determining local-regional extension of prostate cancer.
  Sandler HM, Ohl DA, Quint LE, Bree RL, Seminars in Radiation Oncology 3:169-178
• 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
  Sandler HM, Front Radiat Ther Oncol 29:250-254, Ann Arbor, USA
• 3-D conformal radiotherapy for brain tumors. The University of Michigan experience.
  Sandler HM, Front Radiat Ther Oncol 29:250-254, Ann Arbor, USA
• The National Comprehensive Cancer Network.
  Baker LH, Hanks G, Gershenson D, Kantoff P, Lange P, Logothetis C, Sandler H, Walsh P, NCCN Prostate Cancer Practice Guidelines-Oncology 10:265-88
• The Evan Shapiro case study: Stevens-Johnson syndrome.
  Rao G, Sandler H, Michigan Oncology Journal Summer
• Advances in radiotherapy for prostate cancer.
  Sandler H, McLaughlin P, Michigan Oncology Journal Fall 1998
• Controversies in the management of stage I seminoma.
  Fiveash J, Sandler HM, Oncology 12:1203-1212
• Optimization and clinical use of multisegment IMRT for high dose conformal therapy.
  Fraass BA, Kessler ML, McShan DL, Marsh LH, Watson BA, Dusseau WJ, Eisbruch A, Sandler HM, Lichter AS, Seminars in Radiation Oncology 9:60-77
• Dose escalation with external beam radiotherapy for prostate cancer.
  Sandler HM, Front Radiat Ther Oncol 34:158-164
• Dose escalation for prostate cancer: Which dose for which person?
  Sandler HM, Front Radiat Ther Oncol 36:10-15
• Chemotherapy for localized, high risk prostate cancer.
  Narayan S, Smith DC, Sandler HM, Seminars in Radiation Oncology 13:152-157
• Combined modality treatment for prostate cancer: Role of chemotherapy.
  Sandler HM, Narayan S, Smith DC, Seminars in Radiation Oncology 30(4 Suppl 9):95-100
• Rationale for the Radiation Therapy Oncology Group study RTOG P-0014.
  Sandler HM, Pienta KJ, Rev Urol. 5(suppl 3):S45-S51
• Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer.
  Hollenbeck BK, Dunn RL, Wei JT, Sandler HM, Sanda MG, Current Urology Reports 5:212-219
• Organ preservation in muscle invasive bladder cancer.
  Fernando SA, Sandler HM, Oncology 19:334-339
• Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates—the Massachusetts ...
  Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM, Seminars in Radiation Oncology 15:36-41
• Comparison of two types of ASTRO consensus definitions of biochemical failure: Secondary analysis of Radiation Therapy Oncology Group (RTOG) 92-02 and 94-13.
  Pan CC, Bae K, Hanks G, Shipley W, Roach M, Lawton CA, Sandler HM, Int J Radiat Oncol Biol Phys
• Join now to see all